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Celiac disease and obstetric complications:
a systematic review and metaanalysis
Gabriele Saccone, MD; Vincenzo Berghella, MD; Laura Sarno, MD; Giuseppe M. Maruotti, MD, PhD;
Irene Cetin, MD; Luigi Greco, MD; Ali S. Khashan, PhD; Fergus McCarthy, MD, PhD;
Domenico Martinelli, MD; Francesca Fortunato, MD; Pasquale Martinelli, MDeliac disease is a genetically deter-The aim of this metaanalysis was to evaluate the risk of the development of obstetric
complications in women with celiac disease. We searched electronic databases from
their inception until February 2015. We included all cohort studies that reported the
incidence of obstetric complications in women with celiac disease compared with
women without celiac disease (ie, control group). Studies without a control group and
case-control studies were excluded. The primary outcome was defined a priori and
was the incidence of a composite of obstetric complications that included intrauterine
growth restriction, small for gestational age, low birthweight, preeclampsia and
preterm birth. Secondary outcomes included the incidence of preterm birth, intra-
uterine growth restriction, stillbirth, preeclampsia, small for gestational age, and low
birthweight. The review was registered with PROSPERO (CRD42015017263) before
data extraction. All authors were contacted to obtain the original databases and
perform individual participant data metaanalysis. Primary and secondary outcomes
were assessed in the aggregate data analysis and in the individual participant data
metaanalysis. We included 10 cohort studies (4,844,555 women) in this meta-
analysis. Four authors provided the entire databases for the individual participant dataC mined autoimmune condition,
with an estimated worldwide prevalence
of approximately 1%.1 It usually is
diagnosed by duodenal biopsy that is
performed at the time of endoscopy.1
Celiac disease is induced by the inges-
tion of gluten, and the only treatment
available is the elimination of gluten
from the diet.1
Once considered a gastrointestinal
disease of childhood, celiac disease is
now recognized as a systemic disease.
The most frequent signs and symptoms
are weight loss and chronic diarrhea.1
Complications include disorders of
fertility and pregnancy complications.1,2analysis. Because none of the included studies stratified data for the primary outcome
(ie, composite outcome), the assessment of this outcome for the aggregate analysis
was not feasible. Aggregate data analysis showed that, compared with women in the
control group, women with celiac disease (both treated and untreated) had a signif-
icantly higher risk of the development of preterm birth (adjusted odds ratio, 1.35; 95%
confidence interval, 1.09e1.66), intrauterine growth restriction (odds ratio, 2.48;
95% confidence interval, 1.32e4.67), stillbirth (odds ratio, 4.84; 95% confidence
interval, 1.08e21.75), low birthweight (odds ratio, 1.63; 95% confidence interval,
1.06e2.51), and small for gestational age (odds ratio, 4.52; 95% confidence interval,
1.02e20.08); no statistically significant difference was found in the incidence of
preeclampsia (odds ratio, 2.45; 95% confidence interval, 0.90e6.70). The risk of
preterm birth was still significantly higher both in the subgroup analysis of only women
with diagnosed and treated celiac disease (odds ratio, 1.26; 95% confidence interval,
1.06e1.48) and in the subgroup analysis of only women with undiagnosed and
untreated celiac disease (odds ratio, 2.50; 95% confidence interval; 1.06e5.87).
Women with diagnosed and treated celiac disease had a significantly lower risk of the
development of preterm birth, compared with undiagnosed and untreated celiac
disease (odds ratio, 0.80; 95% confidence interval, 0.64e0.99). The individual
participant data metaanalysis showed that women with celiac disease had a signifi-
cantly higher risk of composite obstetric complications compared with control subjects
(odds ratio, 1.51; 95% confidence interval, 1.17e1.94). Our individual participant
data concurs with the aggregate analysis for all the secondary outcomes. In summary,
women with celiac disease had a significantly higher risk of the development of ob-
stetric complications that included preterm birth, intrauterine growth restriction,
stillbirth, low birthweight, and small for gestational age. Since the treatment with
gluten-free diet leads to a significant decrease of preterm delivery, physicians should
warn these women about the importance of a strict diet to improve obstetric outcomes.
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Future studies calculating cost-effectiveness of screening for celiac disease during
pregnancy, which could be easily performed, economically and noninvasively, are
needed. In addition, further studies are required to determine whether women with
adverse pregnancy outcomes should be screened for celiac disease, particularly in
countries where the prevalence is high.
Key words: celiac disease, metaanalysis, pregnancy, preterm birth, small for gestational
age
FIGURE 1
Flow diagram of studies
identified in the systematic
review
Preferred Reporting Item for Systematic Reviews
and Meta-analyses (PRISMA) template.
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226 American Journal of Obstetrics& GynecologyWomen with unexplained infertility or
recurrent miscarriage were found to
have a signiﬁcantly higher risk of celiac
disease than the general population,
maybe because of the nutrient de-
ﬁciencies and the increased level of
serum autoantibodies.1,2 In 2014 a large
epidemiologic study showed an
increased risk for malformation among
the offspring of mothers or fathers with
celiac disease.3 Moreover, so far, the ef-
fect of a gluten-free diet on prevention of
celiac disease complications in preg-
nancy is still a subject of debate.1
The aim of this metaanalysis was to
evaluate the risk of the development of
obstetric complications in women with
celiac disease.
Methods
Search strategy
This review was performed according to
a protocol designed a priori and rec-
ommended for systematic review.4
Electronic databases (MEDLINE,FIGURE 2
Funnel plot for the assessment of
publication bias
Funnel plot for assessing publication bias. The
symmetric plot suggested no publication bias.
OR, odds ratio; SE, standard error.
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FEBRUARY 2016PROSPERO, Scopus, ClinicalTrials.gov,
EMBASE, Science direct, the Cochrane
Library) were searched from their
inception until February 2015 with no
limit for language. The following search
terms were used: “celiac,” “celiac dis-
ease,” “coeliac,” “coeliac disease,” “pre-
term birth,” “small for gestational age,”
“miscarriage,” “pregnancy,” “prema-
ture,” “newborn,” “low birth weight,”
“fertility,” “preeclampsia,” “recurrent,”
“intrauterine growth restriction,” “still-
birth,” “pregnancy,” “obstetric,” “com-
plications,” and “spontaneous preterm
birth.” No restrictions for language or
geographic location were applied. In
addition, the reference lists of all iden-
tiﬁed articles were examined to identify
studies not captured by electronic
searches. The electronic search and the
eligibility of the studies were assessed
independently by 2 of the authors (G.S.,
V.B.). Differences were discussed, and
consensus reached.
Study selection
We included all cohort studies that re-
ported the incidence of obstetric com-
plications in women with celiac disease
compared with women without celiac
disease (ie, control group). Studies
without a control group and case-
control studies were excluded.
Data extraction
Data abstraction was completed by 2 in-
dependent investigators (G.S., L.S.). Each
investigator independently abstracted
data from each study separately. Data
from each eligible study were extracted
without modiﬁcation of original data
onto custom-made data collection
forms. Disagreements were resolved by
consensus with a third reviewer (P.M.).
Information on potential confounders
that were adjusted for and adjusted risk
estimates were collected when available.
All authors were contacted to obtain the
original databases and perform individual
patient-level metaanalysis.
Two reviewers (G.S., V.B.) indepen-
dently assessed the risk of bias of the
included studies via the Methodological
Index for Non-Randomized Studies.5
Seven domains that are related to risk
of bias were assessed in each study: (1)
TABLE 1
Characteristics of the included studies
Study
Study
location
Study
period Type of study
No. of included
womena Confounders adjusted Outcomes assessed
Sher and Mayberry,
19969
United Kingdom 2005-2006 Prospective cohort 136 (68 vs 68) None Miscarriage,b stillbirth
Martinelli et al, 200010 Italy 1998-1999 Prospective cohort 218 (12 vs 206) Maternal age, previous preterm
birth, socioeconomic status,
smoking
Preterm birth,b stillbirth
Greco et al, 200411 Italy 2001-2002 Retrospective
cohort
5,076 (79 vs 4,997) Maternal age, smoking,
socio-economic status
Intrauterine growth restrictionb
Tata et al, 200512 United Kingdom 1987-2002 Retrospective
cohort
9,244 (1,521 vs 7,723) Socio-economic status Cesarean delivery,b stillbirth,
preeclampsia, intrauterine growth
restriction
Ludvigsson et al, 200521 Sweden 1964-2001 Population-based
cohort
2,817,400 (2,071 vs
2,815,329)
Maternal age, parity, nationality Preterm birth, intrauterine growth
restriction, low birthweightc
Sheiner et al, 200613 Israel 1988-2002 Retrospective
cohort
143,711
(48 vs 143,663)
None Intrauterine growth restriction,b
preeclampsia
McCarthy et al, 200922 Ireland N/R Retrospective
cohort
270 (118 vs 152) Maternal age, maternal body mass
index, gestational age, infant
sex and year of birth
Small for gestational age,b
birthweight
Khashan et al, 201023 Northern Europe 1979-2004 Population-based
cohort
1,504,342 (1,451 vs
1,502,891)
Maternal age, parity, paternal age,
maternal chronic medical conditions
Preterm birth,b small for
gestational age
Martinelli et al, 201024 Italy 2008 Prospective cohort 228 (49 vs 179) None Intrauterine growth restrictionb
Abdul Sultan et al,
201414
United Kingdom 1997-2012 Population-based
cohort
363,930 (892 vs
363,038)
Body mass index, smoking Preterm birth, stillbirth, low
birthweight, preeclampsiac
Total — — — 4,844,555 (6,309 vs
4,838,246)
— —
N/R, not reported.
a Number (N) of included women: total N (N of women with celiac disease vs N of women with no celiac disease); b Primary outcome; c Primary outcome not reported.
Saccone. Celiac disease and obstetric complications. Am J Obstet Gynecol 2016.
ajo
g.o
rg
O
bstetrics
System
atic
R
eview
s
FEB
R
U
A
R
Y
2016
A
m
erican
Journalof
O
bstetrics
&
G
ynecology
227
FIGURE 3
Assessment of risk of bias
A, Summary of risk of bias for each study. Definition of terms: Aim, clearly stated aim; Rate, inclusion
of consecutive patients and response rate; Data, prospective collection of data; Bias, unbiased
assessment of study endpoints; Time, follow-up time appropriate; Loss, loss to follow-up; Size,
calculation of the study size. Definition of symbols:þ, low risk of bias;e, high risk of bias; ?, unclear
risk of bias. B, Risk of bias graph about each risk of bias item presented as percentages across all
included studies.
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Systematic Reviews Obstetrics ajog.orgaim (ie, clearly stated aim), (2) rate (ie,
inclusion of consecutive patients and
response rate), (3) data (ie, prospective
collection of data), (4) bias (ie, unbiased
assessment of study end points), (5) time
(ie, follow-up time appropriate), (6) loss
(ie, loss to follow-up), (7) size (ie,
calculation of the study size).5 Review
authors’ judgments were categorized as
“low risk,” “high risk” or “unclear risk of
bias.” Discrepancies were resolved by
discussion with a third reviewer (P.M.).FIGURE 4
Unadjusted estimates forest plot for
The odds for each study is shown as a blue square,
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test; PTB, preterm bi
Saccone. Celiac disease and obstetric complications. Am J Obste
228 American Journal of Obstetrics& GynecologyThe primary outcome was deﬁned a
priori and was the incidence of a com-
posite of obstetric complications that
included at least 1 of the following
complications: intrauterine growth re-
striction (IUGR; ie, ultrasound estimated
fetal weight <10th percentile for gesta-
tional age), small for gestational age
(SGA; ie, birthweight <10th percentile
for gestational age), low birthweight
(LBW; ie, birthweight <2500 g), pre-
eclampsia, and preterm birth (PTB; ie,the risk of preterm birth in women with
and with a horizontal line showing the confidence in
rth
t Gynecol 2016.
FEBRUARY 2016PTB <37 weeks). Secondary outcomes
included the incidence of PTB, IUGR,
stillbirth, preeclampsia, SGA and LBW.
We planned to assess the incidence of
PTB in a subgroup analysis in women
with treated and untreated celiac disease.
Diagnosed and treated celiac disease
thereafter is called, for simplicity, just
“treated celiac disease”; and undiagnosed
and untreated celiac disease is called, for
simplicity, just “untreated celiac disease.”
Women were classiﬁed as having the
celiac disease diagnosis and treatment
before pregnancy (treated celiac disease)
or afterward (untreated celiac disease).
Data analysis
The data analysis was completed inde-
pendently by 2 authors (G.S., V.B.) with
the use of Review Manager software
(version 5.3; The Nordic Cochrane
Centre, Cochrane Collaboration, 2014,
Copenhagen, Denmark) and Statistical
Package for Social Sciences software
(version 19.0; IBM Inc, Armonk, NY).
Inconsistencies were discussed by the
reviewers, and consensus was reached.
Heterogeneity across studies was
assessed using the Higgins I2 test.4 In
case of statistically signiﬁcant heteroge-
neity (I20%), the random effects
model of DerSimonian and Laird4 was
used; otherwise, a ﬁxed effect model was
performed. The pooled results from the
aggregate metaanalysis were reported as
odds ratio (OR) with 95% conﬁdence
interval (CI). Potential publicationceliac disease
terval. The pooled results for all studies is shown
FIGURE 5
Adjusted estimates forest plot for the risk of preterm birth in women with celiac disease
The odds for each study is shown as a red square, and with a horizontal line showing the confidence interval. The pooled results for all studies is shown as
a black diamond.
CI, confidence interval; IV, independent variable; PTB, preterm birth; SE, standard error
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ajog.org Obstetrics Systematic Reviewsbiases were assessed graphically by the
use of the funnel plot and statistically by
the use of the Begg’s and Egger’s tests.4
In line with other metaanalyses,
no adjustment for risk estimates was
made.4 For studies that reported both
unadjusted and adjusted risk for con-
founders statistically proved, we per-
formed an aggregate data metaanalysis
using generic inverse variance method to
obtain the adjusted odds ratio (aOR) for
the incidence of PTB in the aggregate
data analysis.4,6
To use the data as best as possible, we
also combined the obtained databases to
assess an individual patient-level meta-
analysis. Primary and secondary out-
comes were assessed in both aggregateFIGURE 6
Forest plot for the risk of intrauterine
for gestational age) in women with c
The odds for each study is shown as a blue square,
as a black diamond.
CI, confidence interval; IUGR, intrauterine growth restriction; M-H, M
Saccone. Celiac disease and obstetric complications. Am J Obsteand patient-level data analysis. We
expressed continuous variables as mean
with standard deviation and categoric
variables as number with percentage.
Chi-square test and Fisher’s exact test
were used for categoric variables, and the
Student t test or Mann-Whitney test for
normally and nonnormally distributed
continuous variables, respectively. A
probability value <.05 was considered
statistically signiﬁcant.
The metaanalysis was reported ac-
cording to the Preferred Reporting Item
for Systematic Reviews and Meta-
analyses statement.7 Before data extrac-
tion, the review was registered with the
PROSPERO International Prospective
Register of Systematic Reviewsgrowth restriction (ie, ultrasound estim
eliac disease
and with a horizontal line showing the confidence in
antel-Haenszel test
t Gynecol 2016.
FEBRUARY 2016 Am(registration no.: CRD42015017263)
according to the Preferred Reporting
Item for Systematic Reviews and Meta-
analyses guidelines for protocols.8
Results
Study selection and study
characteristics
The ﬂow of study identiﬁcation is shown
in Figure 1. Seventeen full-text articles
were assessed for eligibility.9-25 Seven
studies were excluded.15-20,25 Six studies
were excluded because they evaluated the
incidence of celiac disease among women
with obstetric complications (ie, case-
control studies),15-20 and one study25
was excluded because it was based on
the same cohort as a more recent study.23ated fetal weight <10th percentile
terval. The pooled results for all studies is shown
erican Journal of Obstetrics& Gynecology 229
FIGURE 7
Forest plot for the risk of stillbirth in women with celiac disease
The odds for each study is shown as a blue square, and with a horizontal line showing the confidence interval. The pooled results for all studies is shown
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test
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Systematic Reviews Obstetrics ajog.orgTen cohort studies, which included
4,844,555women, were analyzed.9-14,21-24
All studies reported the incidence of
obstetric complications in women with
celiac disease compared with women
without celiac disease (ie, control group).
Four studies reported separate analyses
and subgroup analysis for women with
undiagnosed and untreated celiac disease
(ie, untreated celiac disease).11,14,21,23
In all included studies, a diagnosis of
celiac disease was based on either
duodenal biopsy or level of serum
autoantibodies.
The risk of publication bias was
assessed by visual inspection of funnel
plot; the symmetric plot suggested no
publication bias (Figure 2). Publication
bias, which was assessed with the use of
Begg’s and Egger’s tests, showed no sig-
niﬁcant bias (P ¼ .19 and P ¼ .10,FIGURE 8
Forest plot for the risk of low birth w
The odds for each study is shown as a blue square,
as a black diamond.
CI, confidence interval, LBW, low birthweight; M-H, Mantel-Haensze
Saccone. Celiac disease and obstetric complications. Am J Obste
230 American Journal of Obstetrics& Gynecologyrespectively). Table 1 shows the charac-
teristics of the included studies. Most of
them (9 of the 10) originated from
Europe. Eight studies included only
singleton gestations.9-11,14,21-24 The
quality of the studies included in our
metaanalysis was assessed by the Meth-
odological Index for Non-Randomized
Studies’ tool for assessment of the risk
of bias (Figure 3).4 All studies had low
risk of bias in “aim” and most risk in
“rate” and in “time.” Four of the them
were retrospective cohort studies11-13,22;
3 studies were prospective9,10,24; the
other 3 studies were large high-quality
population-based cohort studies.14,21,23
Four authors kindly provided the entire
databases from their study to obtain
additional and unpublished data and
to perform individual patient level
metaanalysis.10,11,22,24eight (ie, birthweight, <2500 g) in wom
and with a horizontal line showing the confidence in
l test
t Gynecol 2016.
FEBRUARY 2016Synthesis of results
Because that none of the included
studies stratiﬁed data for the primary
outcome (ie, composite outcome),
assessment of this outcome for the
aggregate data analysis was not feasible.
Compared with the control group,
women with celiac disease (both treated
and untreated) had a signiﬁcantly higher
risk of the development of PTB (OR,
1.40; 95% CI, 1.18e1.6 [Figure 4]; aOR,
1.35; 95% CI, 1.09e1.66; [Figure 5]),
IUGR (OR, 2.48, 95% CI, 1.32e4.67
[Figure 6]), stillbirth (OR, 4.84; 95% CI,
1.08e21.75 [Figure 7]), LBW (OR, 1.63;
95% CI, 1.06e2.51 [Figure 8]), and SGA
(OR, 4.52; 95% CI, 1.02e20.08
[Figure 9]); no statistically signiﬁcant
difference was found in the incidence of
preeclampsia (OR, 2.45; 95% CI,
0.90e6.70 [Figure 10]).en with celiac disease
terval. The pooled results for all studies is shown
FIGURE 9
Forest plot for the risk of small for gestational age (ie, birthweight,<10th percentile for gestational age) in women
with celiac disease
The odds for each study is shown as a blue square, and with a horizontal line showing the confidence interval. The pooled results for all studies is shown
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test; SGA, small for gestational age
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ajog.org Obstetrics Systematic ReviewsThe risk of PTB was still signiﬁcantly
higher both in subgroup analysis of only
the women with treated celiac disease
(OR, 1.26; 95% CI, 1.06e1.48
[Figure 11]) and in subgroup analysis of
only untreated celiac disease women (OR,
2.50; 95% CI, 1.06e5.87 [Figure 12]).
However, women with treated celiac dis-
ease had a signiﬁcantly lower risk of the
development of PTB compared with
those with untreated celiac disease (OR,
0.80; 95% CI, 0.64e0.99).
Table 2 shows the characteristics of the
women who were included in the indi-
vidual participant datametaanalysis. The
2 groups were similar in terms of
maternal demographics. Four studies
that included 5792 singleton gestations
were analyzed.10,11,22,24 Two hundred
ﬁfty-eight of the women who wereFIGURE 10
Forest plot for the risk of preeclamps
The odds for each study is shown as a blue square,
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test; PE, preeclampsi
Saccone. Celiac disease and obstetric complications. Am J Obsteincluded were womenwith celiac disease
(both treated and untreated); 5534 were
women without celiac disease. Table 3
shows the pooled results of the individual
patient level metaanalysis. Not all the
outcomes have been registered in every
database; results therefore are accompa-
nied with the number of cases in which
the outcomes were registered. Compared
with the control group, women with ce-
liac disease (both treated and untreated)
had a signiﬁcantly higher risk of the
development of PTB (OR, 2.08; 95% CI,
1.36e3.20), IUGR (OR, 5.01; 95% CI,
1.25e20.04), stillbirth (OR, 24.94; 95%
CI, 11.13e55.84), LBW (OR, 6.29; 95%
CI, 1.83e21.60), and SGA (OR, 8.50;
95% CI, 1.85e38.97), ; no statistically
signiﬁcant difference was found in the
incidence of preeclampsia (OR, 20.17;ia in women with celiac disease
and with a horizontal line showing the confidence in
a
t Gynecol 2016.
FEBRUARY 2016 Am95% CI, 0.81e502.43). Using the indi-
vidual participant data metaanalysis, we
were able to assess also the primary
outcome (deﬁned as at least 1 of the
following complications: IUGR, SGA,
LBW, or PTB); womenwith celiac disease
had a signiﬁcantly higher risk of com-
posite obstetric complications compared
with control subjects (OR, 1.51; 95% CI,
1.17e1.94).
Comment
Main ﬁndings
This metaanalysis showed that women
with celiac disease (both treated and
untreated) had a signiﬁcantly higher risk
of the development of obstetric compli-
cations, including PTB, IUGR, stillbirth,
LBW, and SGA; no statistically signiﬁ-
cant difference was found in theterval. The pooled results for all studies is shown
erican Journal of Obstetrics& Gynecology 231
FIGURE 11
Forest plot for the risk of the development of preterm birth in women with treated celiac disease
The odds for each study is shown as a blue square, and with a horizontal line showing the confidence interval. The pooled results for all studies is shown
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test; PTB, preterm birth
Saccone. Celiac disease and obstetric complications. Am J Obstet Gynecol 2016.
Systematic Reviews Obstetrics ajog.orgincidence of preeclampsia. The risk of
PTB was higher both in treated and in
untreated women. However, women
with diagnosed and treated celiac disease
had a 20% signiﬁcant decrease of PTB
compared with those with undiagnosed
and untreated celiac disease at the time
of pregnancy. Our individual patient-
level analysis concurs with the aggre-
gate analysis.
Comparison with existing literature
A previous metaanalysis showed that
celiac disease was associated with
reproductive disorders and pregnancy
complications (ie, unexplained infer-
tility and recurrent miscarriage).2 How-
ever, it did not include all currently
available studies; outcomes that were
considered were different; subgroupFIGURE 12
Forest plot for the risk of the develop
The odds for each study is shown as a blue square,
as a black diamond.
CI, confidence interval; M-H, Mantel-Haenszel test; PTB, preterm bi
Saccone. Celiac disease and obstetric complications. Am J Obste
232 American Journal of Obstetrics& Gynecologyanalyses and individual patient-level
metaanalysis were not performed, and
the number of included women was
lower. Moreover, pooled adjusted risk
estimates were not assessed.2 No other
previous pertinent metaanalyses were
found during the search process.
Strengths and limitations
Our study has several strengths. To our
knowledge, no previous metaanalysis
on this issue is as large or comprehen-
sive. The number of the included
women is very high. Most of the
included studies had low risk of bias.
Statistical heterogeneity between the
studies was low. Individual patient-
level metaanalysis was assessed for
studies in which the original databases
were obtained.ment of preterm birth in women with u
and with a horizontal line showing the confidence in
rth
t Gynecol 2016.
FEBRUARY 2016Limitations of our study are inherent
to the limitations of the included studies.
All the included studies were cohort
studies. Although all authors of the
included studies were contacted, only 4
of them provided the entire database for
the individual patient-level analysis. Data
regarding PTB referred to both sponta-
neous and was indicated as a cause of
PTB. Notably, although the OR was 2.45
for preeclampsia in the celiac vs non-
celiac disease group, this was not statis-
tically signiﬁcant with the frequency
occurring in these 2 groups (2.7% vs
2.8%, respectively; Figure 10). This could
suggest that the difference noted in the
PTB rate between the 2 groupswas due to
a spontaneous cause, such as a preterm
labor or preterm rupture of membranes.
The prespeciﬁed primary outcome ofntreated celiac disease
terval. The pooled results for all studies is shown
TABLE 2
Characteristics of the women included in the individual patient level metaanalysis
Variable
Women with celiac
disease (n[ 258)
Women without celiac
disease (n[ 5534) P value
Mean age, y  SD 27  4.5 26  3.7 .87
Ethnicity
European 25 (98.8) 5504 (99.5) .91
Others, n (%)a 3 (1.2) 30 (0.5)
Mean body mass index,
kg/m2  SD
23  3.2 23  4.4 .92
Smoker, n (%) 25 (9.7) 500 (9.0) .94
Maternal diabetes
mellitus, n (%)
4 (1.6) 105 (1.8) .72
Maternal hypertension or
renal disease, n (%)
5 (1.9) 112 (2.0) .96
Nulliparous, n (%) 113 (43.8) 2190 (39.8) .09
Untreated celiac disease
women, n (%)b
67 (26.0) — —
a Includes Caribbean, Asian, Sub-Saharan Africa, Middle East; b Women who received the celiac disease diagnosis after the index pregnancy.
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ajog.org Obstetrics Systematic Reviewsour review registered on PROSPERO
(CRD42015017263) was an obstetric
complication composite; however,
assessment of this outcome in the
aggregate data analysis was not feasible.
The individual patient-levelmetaanalysis
was post hoc, so it is not reported in the
PROSPERO. Most outcomes had very
high statistical heterogeneity, and this
was a major shortcoming of the meta-
analysis. Older studies may not reﬂect
current practice and outcomes. None ofTABLE 3
Outcomes of the women included in
Outcome
Women w
disease, n
Primary outcomea 107/258 (
Preterm birth 35/91 (3
Intrauterine growth restriction 28/140 (
Stillbirth 9/91 (9
Preeclampsia 33/91 (3
Small for gestational age 43/142 (
Low birthweight 5/12 (4
Note: Not all the outcomes have been registered in every database
as percentage of n, rather than as percentages of the total pop
a Incidence of composite obstetric complications including intra
Saccone. Celiac disease and obstetric complications. Am J Othe included studies adjusted for weight
gain as a possible confounder.
Conclusions and implications
The biologic plausibility to explain the
higher risk of obstetric complications in
women with celiac disease is not
completely clear. However, 2 main hy-
potheses can bemade. Themalabsorption
that characterizes celiac disease may
lead to nutrient deﬁciencies, which can be
associated with adverse pregnancythe individual patient level metaanalysi
ith celiac
/N (%)
Women without
celiac disease, n/N (%)
H
I
41.5) 1,769/5,534 (32.0) 1
8.5) 1,264/5,203 (24.3)
20.0) 298/5,382 (5.6)
.9) 22/5,203 (0.5)
6.3) 512/5,203 (9.9) 7
30.3) 354/5,355 (6.7)
1.7) 21/206 (10.2)
; therefore, results are accompanied with the number of cases in which
ulation.
uterine growth restriction, small for gestational age, low birthweight,
bstet Gynecol 2016.
FEBRUARY 2016 Amoutcomes.26 Speciﬁcally, IUGR, SGA, and
LBW have been associated with maternal
micronutrient deﬁciencies.27 Further-
more, women with celiac disease often
show increased levels of serum autoanti-
bodies, including anti-transglutamines
and anti-thyroid antibodies,1,28-31 that
have been linked to several pregnancy
complications such as PTB and still-
birth.32-34
Because a gluten-free diet reduces
antibodies and leads to an improvements
iggins
2 test, %
Odds ratio
(95% confidence interval)
0 1.51 (1.17e1.94)
0 2.08 (1.36e3.20)
0 5.01 (1.25e20.04)
0 24.94 (11.13e55.84)
8 20.17 (0.81e502.43)
5 8.50 (1.85e38.97)
0 6.29 (1.83e21.60)
the outcomes were registered (n). Proportions are presented
preeclampsia, and preterm birth.
erican Journal of Obstetrics& Gynecology 233
Systematic Reviews Obstetrics ajog.orgof intestinal function and nutrient
availability,1,35-37 this may explain the
reason that treated women with celiac
disease have better pregnancy outcomes
than untreated women.
In summary, women with celiac disease
(both treated and untreated) had a signif-
icantly higher risk of the development of
obstetric complications. Because the
treatment with gluten-free diet leads to a
signiﬁcant decrease of PTB, physicians
should warn these women about the
importance of a strict diet to improve ob-
stetric outcomes. Future studies that will
calculate the cost-effectiveness of screening
for celiac disease during pregnancy, which
could be performed easily, economically,
and noninvasively,38 are needed. In addi-
tion, further studies are required to deter-
mine whether women with adverse
pregnancy outcomes should be screened
for celiac disease, particularly in countries
where the prevalence is high. -REFERENCES
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